These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31486756)

  • 21. Prevalence and determinants of glucose intolerance among HIV/AIDS patients in north-central Nigeria.
    Reng SR; Uloko EA; Puepet HF; Onwuegbuzie AG; Ramalan AM
    Niger J Med; 2016; 25(2):128-32. PubMed ID: 29944309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short- and Long-term Risks of Highly Active Antiretroviral Treatment with Incident Opportunistic Infections among People Living with HIV/AIDS.
    Yen YF; Chen M; Jen IA; Chuang PH; Lee CY; Lin SI; Chen YA
    Sci Rep; 2019 Mar; 9(1):3476. PubMed ID: 30837537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical spectrum of neurological manifestations in HIV/AIDS patients on HAART at the Lagos University Teaching Hospital, Lagos, Nigeria.
    Oshinaike OO; Okubadejo NU; Ojini FI; Danesi MA
    Nig Q J Hosp Med; 2009; 19(4):181-5. PubMed ID: 20836327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy.
    Shikuma CM; Hu N; Milne C; Yost F; Waslien C; Shimizu S; Shiramizu B
    AIDS; 2001 Sep; 15(14):1801-9. PubMed ID: 11579242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of earlier HAART initiation on the immune status and clinical course of treated patients on the basis of cohort data of the German Competence Network for HIV/AIDS.
    Plettenberg A; Brockmeyer NH; Haastert B; Michalik C; Dupke S; Schewe K; Rausch M; Hower M; Ulmer A; Wolf E; Lorenzen T; Arendt G; Jansen K;
    Infection; 2011 Feb; 39(1):3-12. PubMed ID: 21221704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of highly active antiretroviral treatment with incident tuberculosis in people living with HIV/AIDS.
    Yen YF; Jen IA; Chuang PH; Chen M; Lan YC; Lee CY; Arthur Chen YM
    Ann Epidemiol; 2018 Dec; 28(12):886-892.e3. PubMed ID: 29656849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and echocardiographic findings in a cross-sectional study of HIV-infected adults in Enugu, Nigeria.
    Njoku PO; Ejim EC; Anisiuba BC; Ike SO; Onwubere BJ
    Cardiovasc J Afr; 2021 Nov-Dec 23; 32(6):320-326. PubMed ID: 34128946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrocardiographic findings in a cross-sectional study of human immunodeficiency virus (HIV) patients in Enugu, south-east Nigeria.
    Njoku PO; Ejim EC; Anisiuba BC; Ike SO; Onwubere BJ
    Cardiovasc J Afr; 2016; 27(4):252-257. PubMed ID: 27841913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidative stress and mitochondrial impairment after treatment with anti-HIV drugs: clinical implications.
    Blas-Garcia A; Apostolova N; Esplugues JV
    Curr Pharm Des; 2011 Dec; 17(36):4076-86. PubMed ID: 22188456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondrial toxicity studied with the PBMC of children from the Chinese national pediatric highly active antiretroviral therapy cohort.
    Liu K; Sun Y; Liu D; Yin J; Qiao L; Shi Y; Dong Y; Li N; Zhang F; Chen D
    PLoS One; 2013; 8(2):e57223. PubMed ID: 23468942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteomic analysis identifies prohibitin down-regulation as a crucial event in the mitochondrial damage observed in HIV-infected patients.
    Ciccosanti F; Corazzari M; Soldani F; Matarrese P; Pagliarini V; Iadevaia V; Tinari A; Zaccarelli M; Perfettini JL; Malorni W; Kroemer G; Antinori A; Fimia GM; Piacentini M
    Antivir Ther; 2010; 15(3):377-90. PubMed ID: 20516557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
    Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
    Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective study of highly active antiretroviral therapy in Indian human immunodeficiency virus positive patients.
    Rajesh R; Vidyasagar S; Varma DM; Naik A; Hegde BM; Guddattu V; Kamath A
    Int J Risk Saf Med; 2013 Jan; 25(1):53-65. PubMed ID: 23442298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA study.
    Cozzi Lepri A; Phillips AN; d'Arminio Monforte A; Castelli F; Antinori A; de Luca A; Pezzotti P; Alberici F; Cargnel A; Grima P; Piscopo R; Prestileo T; Scalise G; Vigevani M; Moroni M;
    AIDS; 2001 May; 15(8):983-90. PubMed ID: 11399980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution of mitochondrial DNA content after planned interruption of HAART in HIV-infected pediatric patients.
    Noguera A; Morén C; Rovira N; Sànchez E; Garrabou G; Nicolàs M; Muñoz-Almagro C; Cardellach F; Miró O; Fortuny C
    AIDS Res Hum Retroviruses; 2010 Sep; 26(9):1015-8. PubMed ID: 20707732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4+ cells recovery in HIV positive patients with severe immunosuppression at HAART initiation at Centre Medico-Social Cor-Unum, Kigali.
    Merci NM; Emerence U; Augustin N; Habtu M; Julie I; Angelique T; Jessica B; Cynthia A; Penda AT
    Pan Afr Med J; 2017; 26():14. PubMed ID: 28450993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Analysis on antiretroviral therapy efficacy for HIV/AIDS in Zhejiang province, 2009-2014].
    Zheng JL; Xu Y; He L; Jiang J; Zhang JF; Zhang WJ; Ding XB; Yang JZ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 May; 37(5):673-7. PubMed ID: 27188360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial evolution in HIV-infected children receiving first- or second-generation nucleoside analogues.
    Morén C; Noguera-Julian A; Garrabou G; Catalán M; Rovira N; Tobías E; Cardellach F; Miró Ò; Fortuny C
    J Acquir Immune Defic Syndr; 2012 Jun; 60(2):111-6. PubMed ID: 22362155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Highly active antiretroviral therapy drug combination induces oxidative stress and mitochondrial dysfunction in immortalized human blood-brain barrier endothelial cells.
    Manda KR; Banerjee A; Banks WA; Ercal N
    Free Radic Biol Med; 2011 Apr; 50(7):801-10. PubMed ID: 21193030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood mitochondrial DNA mutations in HIV-infected women and their infants exposed to HAART during pregnancy.
    Jitratkosol MH; Sattha B; Maan EJ; Gadawski I; Harrigan PR; Forbes JC; Alimenti A; van Schalkwyk J; Money DM; Côté HC;
    AIDS; 2012 Mar; 26(6):675-83. PubMed ID: 22436539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.